Analyzing IRS Determination Letter 202518023: Navigating the Deductibility of IVF and Gestational Surrogacy Costs Under IRC §213
As tax professionals, we frequently encounter complex medical expense deduction questions under IRC Section 213. IRS Determination Letter 202518023 provides valuable insight into the Service’s position on the deductibility of costs associated with in vitro fertilization (IVF) and gestational surrogacy. This analysis will dissect the facts presented, the taxpayers’ request, the IRS’s legal framework, its application of the law, and the final determination.
Read More